Product Information
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Cipla USA Inc., priced at $1.1640 per EA under NDC 69097021002. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on Jun 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB
efavirenz, emtricitabine and tenofovir disoproxil fumarateStrength
600; 200; 300 mg/1; mg/1; mg/1
Manufacturer
Cipla USA Inc.NDC
69097021002
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206894FDA Approved
6/3/2019
TE Code
AB
On Market Since
3/30/2021
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 277 times since May 5, 2021, and over the history we have for it it has declined 98.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1640 per EA |
|---|---|
| All-time high | $75.3743 (May 12, 2021) |
| All-time low | $1.1460 (Jul 17, 2024) |
| 52-week high | $1.4988 |
| 52-week low | $1.1634 |
| Median price | $1.7007 |
| Average price | $3.7093 |
| Largest weekly change | -89.2% (May 19, 2021) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the efavirenz, emtricitabine and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Cipla USA Inc., is $1.1640 per EA (NDC 69097021002), effective Aug 19, 2026.
How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 98.5%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
Since May 5, 2021, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.1460 (Jul 17, 2024) to a high of $75.3743 (May 12, 2021), with a median of $1.7007 per EA.
Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 69097021002) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.